CLOs on the Move

Ausepx Pharma

www.auspexpharma.com

 
Auspex Pharmaceuticals, Inc. develops deuterated analogs of clinically-validated drugs. Its technology replaces metabolically-sensitive hydrogen atoms with its non-radioactive isotope deuterium to create therapeutics. The company was founded in 2001 and is based in La Jolla, California.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

Raytel Medical Corporation

Raytel Medical Corporation is a Windsor, CT-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Global Marketing Resources Inc

Global Marketing Resources Inc is a Dunedin, FL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Framingham Heart Study

Since our beginning in 1948, the Framingham Heart Study, under the direction of the National Heart, Lung and Blood Institute (NHLBI), formerly known as the National Heart Institute, has been committed to identifying the common factors or characteristics that contribute to cardiovascular disease (CVD). We have followed CVD development over a long period of time in three generations of participants.

Talcomp

Talcomp is a Houston, TX-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Massive Bio

Increasing Accessibility to Clinical Trials and Personalized Cancer Treatment Options. Every cancer patient is different and deserves treatment of the highest quality that is personalized, affordable, and easily accessible. Massive Bio translates the world-class oncology knowledge of the large cancer centers​ experts, facilitates a virtual tumor board collaboratively with the treating oncologist, and advises the patient and treating oncologist to operationalize these expert recommendations at the point of care thereby, eliminating additional time, travel, and cost. 85% of US cancer patients receive treatments in community practices where treating oncologists are overwhelmed with the influx of new tests and treatments while trying to manage their busy practices. We believe all cancer patients deserve equal access to the latest in cancer research and treatment.